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The physiological importance oÍ saliva in human becomes obvious when saliva is
secreted to a too large (hypersalivation) or a too small (hyposalivation) extent. The
reduced salivary secretion results in a wide scale of complaints such as a dry and
burning sensation oÍ the mouth, and diff iculties in chewing, swallowing, speaking
and sleeping. To combat these complaints, the lack oÍ saliva has to be compensated.
A large number oÍ remedies has been developed to reduce or prevent these
complaints. The majority oÍ these remedies can only be applied in patients in whom
salivary Ílow can be increased. The other remedies are meant as a (partial) saliva
replacement. The eÍfect of all these remedies is not optimal Íor a large group oÍ
patients; Íurther investigations were needed.
To treat patients sufÍering Írom a reduced salivary Ílow effectively, an investigation
was carried out. The aims oÍ this study were:
1. Development oÍ a saliva substitute which approximates the chemical and
physiochemical properties oÍ human whole saliva;
2. Development oÍ a suitable method oÍ application;
3. Evaluation oÍ the meaning oÍ the developed substitute Íor the patient.
Chapter 2 reviews the morphology and innervation oÍ the salivary glands, and the
composition and Íunction of saliva. Only those aspects are mentioned, which are oÍ
importance Íor a better understanding of the results oÍ a decreased salivaryÍlow and
Íor composing a saliva substitute. The most important components oÍ human whole
saliva are water, glycoproteins and the electrolytes odium, potassium, calcium,
magnesium, phosphate and chloride. The main Íunctions are the moistening,
protection and lubrication of the soft and hard oral and pharyngeal t issues.
The causes and main consequences oÍthe reduced salivary secretion are discussed
in Chapter 3. A large number of physiological and pathological processes can cause
a reduction oÍthe salivary Ílow, but mostly to a minorextent. The mostsevere Íorms oÍ
xerostomia re observed aÍter radiation oÍ malignant umours in the head and neck
region, in particular iÍ the salivary glands are completely included in the treatment
portals, in Sjógren's syndrome and after the use oÍ certain medicines (e.9. cytostatics,
antihypertensives and psychotropic medicaments). The most pronounced results of
xerostomia are dry and burning sensation oÍ the mouth, difÍ icult ies in chewing,
swallowing, speaking and sleeping, progressive carious destruction oÍthe teeth and
Írequently occurring oral inÍections.
In Chapter 4 some remedies are l isted which are used in patients suffering Írom
xerostomia. A curative therapy should be prescribed iÍ possible. For the other
patients only a symptomatic treatment remains. The latter is made up of the
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stimulation oÍ the salivary secretion by means of gustatory (a.o. citric acid, vitamine
c) ,  tact i le  (a.o.  chewing gum) and pharmacological  (a.o.  anethol t r i t ion,  p i locarp ine)
s ia logogues and/or  the appl icat ion of  mouthwashes and more complex sal iva
substitutes. These saliva substitutes have been developed to take over the functions
of saliva, this has only partially been succesÍul.
chapter 5 describes the development oÍ the mucin(glycoproteins)-containing saliva
substitute. The mucin material was preferred to the other viscosity-increasing
expedients, because precisely these glycoproteins determine the rheologic and
wett ing behaviour  oÍ  human whole sal iva.  The most  pronounced d i Í Íerence oÍ  the
carboxymethylcellulose(CMC)-containing saliva substitutes is the substitution oÍ
CMC and sorb i to l  by animal  g lycoprote ins (p ig gastr ic  mucin (pGM) and bovine
submandibular  mucin (BSM))  and xy l i to l .  subsequent ly  the wet t ing,  rheological ,
remineralizing, buÍÍering and osmotic properties oÍ the developed substitute are
compared wi th those of  the cMc-conta in ing sal iva subst i tu tes and human whole
saliva.
The wetting behaviour of all those liquids was determined by means oÍ contact angle
measurements on human ground and pol ished enamel  ( in  v i t ro)  and human ora l
mucosa (in vivo). From these measurements it was concluded that:
1.  the contact  angles oÍ  water  and CMC- or  mucin-conta in ing sal iva subst i tu tes are
s igni f icant ly  lower than those of  human whole sal iva on ground and pol ished
enamel, indicating the better wetting oÍ the prepared enamel by the tormer;
2. the contact angle of water on human mucosa is significantly higher than that oÍ
human whole saliva indicating that water is a poor wetting agent Íor the oral
mucosa;
3.  the contact  angles oÍ  the CMC-preparat ions and human whole sal iva are
comparable on the human mucosa, although the ratio 7!l7q differs greatly;
4. the contact angles oÍ the mucin-preparations and human whole saliva are
comparable on the human mucosa; the ratio y!/ y0,is comparable. This indicates
that the mucin-preparations are better wetting agents oÍ the oral mucosa than
human whole sal iva.
The rheological  behaviour  oÍ  a l l  these l iqu ids was determined by means of
measuring the apparent viscosity of these mixtures as a function oÍ shear rate (in
vitro). From these measurements it was concluded that:
1.  the cMC-conta in ing sal iva subst i tu tes are non-Newtonian l iqu ids wi th in the
range of shear rates studied. In all cases the apparentviscosity decreases l ightly
with increasing shear rate;
2.  ar t i f ic ia l  sa l iva conta in ing BSM or  a mixture oÍ  BSM and PGM qual i ta t ive ly
approaches the visco-elastic properties oÍ human whole saliva.
The remineral iz ing behaviour  oÍ  a l l  these l iqu ids was determined by means oÍ
hardness measurements (rehardening) on soÍtened human enamel. The softened
enamel  was exposed to the test ing l iqu ids dur ing some hours or  days ( in  v i t ro) .  From
these measurements it was concluded that:
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1. saliva substitutes containing calcium, phosphate and Íluoride have potentially
rehardening properties;
2. the rehardening is better in the case oÍ CMC-containing saliva substitutes than in
that containing mucin;
3. the addition oÍ CMC, mucin, sorbitol or xylitol to an aqueous solution containing
calcium, phosphate and fluoride decreases the rehardening potency.
4. the addition oÍ sorbitol reduces the rehardening potential to a greater extent han
the addition of xylitol.
In  addi t ion,  the mucin-  as wel l  as the CMC-conta in ing sal iva subst i tu tes both have a
minor buffering capacity (phosphate component in the substitutes), which was much
lower than that of human whole saliva. The osmolality oÍ all substitutes tested
exceeds that oÍ saliva; in the case oÍ the CMC-containing saliva substitutes it even
resembles or exceeds that of blood, which may cause a dehydration oÍ the oral
mucosa.
In Chapter 6 a new method of application is introduced, the intra-oral artiÍ icial saliva
reservoir. When applying artif icial saliva in this way the oral cavity is continuously
moistened for a period of, on average, Íour hours. The intra-oral artiÍ icial saliva
reservoir can be applied in dentulous and edentulous patients. In edentulous
patients the reservoir is located in a thickening oÍ the oral side of the upper denture
and in the bulk oÍ a lower denture. In a dentulous patientthe reservoir is clasped like a
palatal prosthesis to the dentit ion. The reservoir may be applied in patients, who:
'1 
. can manage artif icial saliva well;
2. have sufficient volume for a reservoir in the oral cavity;
3. can tolerate a reduced oral space.
Chapter 7 shows the effect of the developed substitute on the patient's complaints oÍ
xerostomia. In the Íirst part oÍ this chapter the effect of the developed substitute was
compared to thatoÍ commercially available CMC-containing substitutes in a clinical
trial. From this study it could be concluded that the majority oÍ the patients preÍerred
the mucin-containing saliva substitute. Subsequently in the second part oÍ this
chapter it was investigated whether the mucin-contai ni ng substitute was an etÍective
relieÍ bringing remedyÍor the patient sufÍering Írom xerostomia. From this study it was
concluded that:
1 . the appl ication of the mucin-containing saliva substitute reduces the sensation oÍ
a dry mouth as well as improving oral Íunctioning (in particular chewing,
swallowing, speaking and sleeping);
2. the patient's perceived emotional impact concerning oral Íunctioning improves;
3. the application oÍ the mucin-containing saliva substitute reduces the number oÍ
restrictions in the daily Íunctioning oÍ the patient, resulting in a more normal





In conclusion it can be stated that:
1. the developed mucin-containing saliva substitute exceeds the rheological and
wetting properties oÍ the available CMC-containing saliva substitutes;
for a l imited group of patients (see Chapter 6), the developed method of
application can guarantee a continuous wetting of the oral cavity Íor about two
nours;
the developed mucin-containing saliva substitute is an eÍÍective, relieÍ bringing
remedy.
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